|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 9/16 | (2006.01) |
| A61K 31/485 | (2006.01) | ||
| A61P 25/04 | (2006.01) |
| (11) | Number of the document | 3866765 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19874338.7 |
| Date of filing the European patent application | 2019-10-15 | |
| (97) | Date of publication of the European application | 2021-08-25 |
| (45) | Date of publication and mention of the grant of the patent | 2024-02-07 |
| (46) | Date of publication of the claims translation | 2024-04-25 |
| (86) | Number | PCT/KR2019/013535 |
| Date | 2019-10-15 |
| (87) | Number | WO 2020/080806 |
| Date | 2020-04-23 |
| (30) | Number | Date | Country code |
| 201862745805 P | 2018-10-15 | US |
| (72) |
YOON, Gwangheum , US
SOH, Bong Kwan , US
OTTE, Andrew David , US
PARK, Kinam , US
|
| (73) |
Chong Kun Dang Pharmaceutical Corp. ,
8, Chungjeong-ro
Seodaemun-gu, Seoul 03742,
KR
Purdue Research Foundation , 1801 Newman Road, West Lafayette, Indiana 47906, US |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Injekcinė ilgai veikianti naltreksono mikrodalelių kompozicija |
| INJECTABLE LONG-ACTING NALTREXONE MICROPARTICLE COMPOSITIONS |
| Payment date | Validity (years) | Amount | |
| 2024-10-17 | 6 | 208.50 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2025-08-27 |